[Antimicrobial and cytostatic properties of 6-hydroxy-1,3-benzoxathiol-2-one (01 1)].
D000818:Animals; D000873:Anthracenes / Q000494:pharmacology; D000891:Anti-Infective Agents, Local / Q000494:pharmacology*; D001230:Aspergillus / Q000187:drug effects; D001412:Bacillus subtilis / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects*; D001884:Bordetella / Q000187:drug effects; D002175:Candida / Q000187:drug effects; D002417:Cattle; D002455:Cell Division / Q000187:drug effects*; D002460:Cell Line; D002642:Chick Embryo; D003013:Clostridium / Q000187:drug effects; D003352:Corynebacterium / Q000187:drug effects; D046508:Culture Techniques; D003864:Depression, Chemical; D004847:Epithelial Cells; D004926:Escherichia coli / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects; D005658:Fungi / Q000187:drug effects*; D006367:HeLa Cells / Q000187:drug effects; D006854:Hydrocortisone / Q000494:pharmacology; D007668:Kidney / Q000166:cytology; D007709:Klebsiella / Q000187:drug effects; D007783:Lactones / Q000494:pharmacology*; D008938:Mitosis / Q000187:drug effects; D009089:Mucor / Q000187:drug effects; D009161:Mycobacterium / Q000187:drug effects; D010325:Pasteurella / Q000187:drug effects; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012440:Saccharomyces / Q000187:drug effects; D012475:Salmonella / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D014249:Trichophyton / Q000187:drug effects
D000873:Anthracenes; D000891:Anti-Infective Agents, Local; D007783:Lactones; D006854:Hydrocortisone
Die antimikrobiellen und cytostatischen Eigenschaften von 6-hydroxy-1,3-benzoxanthiol-2-on (01 1)